SCHEMBL8795485

SCHEMBL8795485

c1ccc(C2=NOCCO2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.39
ITGB2 P05107 1/20 0.39
ICAM1 P05362 1/20 0.39
ITGAL P20701 1/20 0.39
SMN1; SMN2 Q16637 6/20 0.36
NPC1 O15118 6/20 0.36
RAB9A P51151 6/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
MAPK1 P28482 2/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
MAPK10 P53779 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CRHBP P24387 2/20 0.34
CRHR2 Q13324 2/20 0.34
HTT P42858 1/20 0.34
GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4397209 0.79 LMNA (0.40) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL10338080 0.78 NPC1 (0.39) SMN1; SMN2NPC1RAB9AMAPTUSP2
SCHEMBL7839776 0.77 HSD17B1 (0.46) LMNAALDH1A1HSD17B10
SCHEMBL7840064 0.74 CYP2D6 (0.38) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL84185 0.73 KCNN4 (0.47) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL21351777 0.73 KCNN4 (0.47) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL3243868 0.72 ITGB2 (0.48) LMNAITGB2ICAM1ITGALSMN1; SMN2
SCHEMBL9566190 0.71 KCNN4 (0.46) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL961792 0.70 KCNN4 (0.44) SMN1; SMN2ALDH1A1NISCH
SCHEMBL9162288 0.70 LMNA (0.37) LMNAITGB2ICAM1ITGALSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185571-B1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS UNIV OF KWAZULU NATAL (ZA) 2026-05-20 EP claimed
US-12441721-B2 Synthesis of heterocyclic compounds from carboxamide and carboxamide derivatives with haloalkanols UNIVERSITY OF KWAZULU-NATAL (ZA) 2025-10-14 US claimed
US-20230295139-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS UNIVERSITY OF KWAZULU-NATAL (ZA) 2023-09-21 US claimed
EP-4185571-B1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS UNIV OF KWAZULU NATAL (ZA) 2026-05-20 EP disclosed
US-12441721-B2 Synthesis of heterocyclic compounds from carboxamide and carboxamide derivatives with haloalkanols UNIVERSITY OF KWAZULU-NATAL (ZA) 2025-10-14 US disclosed
EP-4556468-A2 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS University of KwaZulu-Natal (ZA) 2025-05-21 EP disclosed
US-20230295139-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS UNIVERSITY OF KWAZULU-NATAL (ZA) 2023-09-21 US disclosed
US-20230295139-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS UNIVERSITY OF KWAZULU-NATAL (ZA) 2023-09-21 US disclosed
US-20230295139-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS UNIVERSITY OF KWAZULU-NATAL (ZA) 2023-09-21 US disclosed
EP-4185571-A2 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS University Of Kwazulu-Natal (ZA) 2023-05-31 EP disclosed
CN-116057047-A Synthesis of heterocyclic compounds from carboxamides and carboxamide derivatives and haloalkanols 夸祖鲁-纳塔尔大学 2023-05-02 CN disclosed
EP-0645386-B1 N-Azinyl-N'-(het)arylsulfonylureas as herbicides BAYER AG (DE) 1997-12-29 EP disclosed
US-5476936-A Herbicides BAYER AKTIENGESELLSCHAFT (DE) 1995-12-19 US disclosed
EP-0645386-A1 N-Azinyl-N'-(het)arylsulfonylureas as herbicides BAYER AG (DE) 1995-03-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12441721-B2 Synthesis of heterocyclic compounds from carboxamide and carboxamide derivatives with haloalkanols NAAA, CNR2, AADAC LMNA 3368/4885ITGB2 4488/4885ICAM1 4712/4885
US-20230295139-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS FROM CARBOXAMIDE AND CARBOXAMIDE DERIVATIVES WITH HALOALKANOLS NAAA, CNR2, AADAC LMNA 3368/4885ITGB2 4488/4885ICAM1 4712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.